Tree MATA MPL

BIOLOGICAL2 trials

Sponsors

Allergy Therapeutics

Conditions

Type I Hypersensitivity

Phase 1

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

CompletedNCT00107705

Allergy TherapeuticsType I Hypersensitivity

Start: 2005-04-30End: 2005-05-31Target: 12Updated: 2010-06-17

Phase 2

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

CompletedNCT00118625

Allergy TherapeuticsType I Hypersensitivity

Start: 2005-07-31End: 2005-09-30Target: 40Updated: 2010-06-17